Response,Percentage of glaucoma market
Oral carbonic anhydrase inhibitors and other,2%
Topical carbonic anhydrase inhibitors,5%
Alpha agonist,10%
Fixed combo,14%
Beta blocker,13%
Latanoprost**,41%
Travatan Z**,6%
Lumigan**,7%
